Physician profile
Thomas Gernon
NPI 1548387525
$5,431.73
in general payments reported to CMS, 2019-2025
7 companies · $27.59 in 2025
The $27.59 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,046 · 2021: $172 · 2023: $55.75 · 2024: $130 · 2025: $27.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,081.27 | 2020-2024 | |
| Kls-Martin L.P. | $125.00 | 2021 | |
| Merck Sharp & Dohme LLC | $71.73 | 2024 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $50.95 | 2024-2025 | Imfinzi |
| Acera Surgical, INC. | $47.03 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.84 | 2023 | Alunbrig |
| Mirati Therapeutics, INC. | $25.91 | 2023 | Krazati |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gernon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.